Conference Call to be on Wednesday, January 18, at 4:15 PM ET
Simulations Plus Reports FY2011 and Fourth Quarter FY2011 Financial Results
Fiscal Year Pharmaceutical Software and Services Up 14.7%, EPS Up 29.3%
Simulations Plus Sets Date for 4th Quarter and Fiscal Year 2011 Earnings Release and Conference Call
Conference Call to be on Thursday, December 1, 2011 at 4:30 PM EST
Simulations Plus Signs Stock Purchase Agreement for Sale of Words+ Subsidiary
Prentke Romich Company to Acquire Subsidiary and Continue Operations
Simulations Plus Completes Molecule Design Phase, Issues RFQs for Molecule Synthesis
Company Uses Proprietary Software Tools to Design New Drug-like Molecules for Resistant Malaria Parasite
Simulations Plus Reports Preliminary Revenues for Fourth Fiscal Quarter and FY2011
Pharmaceutical Software and Services Revenues Increase 6.9% for 4th Quarter, up 14.7% for the Fiscal Year
SLP Subsidiary Words+ Launches EyePro GS™ System
In-house Design Widens Eye Gaze Offerings and Substantially Increases Margins
Simulations Plus Reports Third Quarter FY2011 Financial Results and Announces Investor Conference Call
Record Quarterly Revenue of $3.44 Million; Consolidated Earnings Up 42% and EPS Up 49% from 3QFY10
Simulations Plus Reports Preliminary Revenues for Third Fiscal Quarter of FY2011
Growth Trend Continues with Another Record Quarter
Simulations Plus Sets Date for 2nd Quarter 2011 Earnings Release and Conference Call
Conference Call to Be on Monday, April 18, at 4:15 PM EDT
Simulations Plus (SLP) Releases MedChem Studio 2.0
Adds New MedChem Designer Molecule Drawing, Expanded Graphics, and More
Simulations Plus Reports Preliminary Revenues for Second Fiscal Quarter of FY2011
String of Record Quarters Sustains Multi-Year Growth Trend
Simulations Plus (“SLP”) Releases ADMET Predictor Version 5.5
New Predictions Further Extend Best-in-Class Software
Simulations Plus (“SLP”) Launches MedChem Designer
Powerful Molecule Drawing Tool Added to World-Class Product Line
Simulations Plus to Collaborate with FDA to Develop Predictive Toxicity Models
Center for Food Safety and Applied Nutrition (CFSAN) to Provide Data
Simulations Plus Reports First Quarter FY2011 Financial Results
Pharmaceutical Software and Services Revenues Up 18%, Words+ Subsidiary Up 8.3%, Consolidated Earnings Up 32%, and EPS Up 34% from 1QFY10
Simulations Plus Sets Date for 1st Quarter 2011 Earnings Release and Conference Call
Conference Call to be on Friday, January 14, at 11:00 AM EST
Simulations Plus Reports Preliminary Revenues for First Fiscal Quarter of FY2011
Record First Quarter and Sustained Multi-year Growth Trend